Courtesy Of Our Commenters, We Learn Generic Daraprim Is Now Selling In US, At A 60% "Discount"... Still Outrageous.

The press in India is [now finally] reporting that Cerovene has struck a US distribution deal with stalwart high price generic manufacturer Dr. Reddy's Labs -- and the generic is now selling here stateside. Of course, this is still. . . deeply obscene.

The price, pre-Martin's mark-up, per pill, was only $13.50. His 2015 markup kicked it to $750. At 60 per cent off the Martin markup, it is to be sold in the US at $300, give or take. That is still over 22 times its prior price -- before Martin gouged the nation's vulnerable AIDS patients. [Backgrounder, here.]

So there is still much work to be done -- yet 22X is better than 50X -- even as Phoenixus presumbly fades away, into. . . a dead, dry dust. According to the local Indian papers, Phoenixus only sold about $10 million of the branded version of the drug, in all of 2019:

. . . .The Daraprim (pyrimethamine) brand had US sales of about $10 million for the most recent 12 months ending in January 2020, according to IQVIA Health. . . .

Immensely. . . frustrating. Thanks, again Marty. Sheesh.

Onward -- I resolve to smile, anyway.

नमस्ते